New Assay Detects Growth Hormone Secretagogue Receptor Antagonists in Urine
Early Detection of Growth Hormone Secretagogue Receptor Antagonists Exploiting Their Atypical Behavior in Competitive Assays.
Background
Growth Hormone Secretagogue Receptor 1a (GHS-R1a) antagonists are compounds that block the receptor for ghrelin, a hormone known to stimulate growth hormone release and appetite. Due to their potential to modulate growth hormone levels and their use as doping agents in sports, there is a critical need for sensitive and early detection methods. Current analytical approaches may not fully exploit the unique pharmacological characteristics of these substances, leading to a knowledge gap in efficient screening; this study addresses this by developing a novel bioaffinity format that leverages the atypical binding behavior of GHS-R1a antagonists for enhanced detection.